Search filters

List of works by Pier Adelchi Ruffini

A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer

scientific article published on 10 January 2020

Armed antibodies for cancer treatment: a promising tool in a changing era.

scientific article

CXCR1/2 inhibition blocks and reverses type 1 diabetes in mice

scientific article

CXCR1/2 inhibition enhances pancreatic islet survival after transplantation

scientific article

CXCR1/2 pathways in paclitaxel-induced neuropathic pain

scientific article

Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo

scientific article published on 10 June 2004

Chemotherapy-related cardiotoxicity: new diagnostic and preventive strategies.

scientific article published on October 2003

Cloning of B cell lymphoma-associated antigens using modified phage-displayed expression cDNA library and immunized patient sera

scientific article

Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer

scientific article published on 20 May 2020

Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis

scientific article published on 9 April 2004

Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin's lymphoma

scientific article

Germ cell tumors overexpress the candidate therapeutic target cyclin B1 independently of p53 function.

scientific article published on 22 July 2015

Human chemokine MIP1α increases efficiency of targeted DNA fusion vaccines

scientific article published on 4 November 2010

Idiotype-specific immunotherapy in multiple myeloma: suggestions for future directions of research.

scientific article published on July 2006

Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.

scientific article

Intralesional treatment of stage III metastatic melanoma patients with L19-IL2 results in sustained clinical and systemic immunologic responses.

scientific article published on 4 April 2014

Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer

article

Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patients

Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2-Negative Metastatic Breast Cancer.

scientific article published on 24 May 2017

Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer.

scientific article published in May 2010

Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trial

scientific article

Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice

scientific article

Targeted idiotype-fusion DNA vaccines for human multiple myeloma: preclinical testing

scientific article published on 30 March 2011

Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling

scientific article published on 26 October 2015

Targeting CXCR1/2 Does Not Improve Insulin Secretion After Pancreatic Islet Transplantation: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Type 1 Diabetes

scientific article published on 04 February 2020

The CXCL8-CXCR1/2 Axis as a Therapeutic Target in Breast Cancer Stem-Like Cells

scientific article published on 06 February 2019

Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2.

scientific article

Paulina is supported by:

About Paulina

Help